Imaging Drug for Cancer Lymph Nodes Gets FDA Nod

by Kathy Jones on  March 15, 2013 at 8:48 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new drug to help doctors home in on lymph nodes in breast cancer patients has received the nod from the Food and Drug Administration.
 Imaging Drug for Cancer Lymph Nodes Gets FDA Nod
Imaging Drug for Cancer Lymph Nodes Gets FDA Nod

The drug called Lymphoseek is developed by Navidea Biopharmaceuticals Inc. It can help doctors determine if the breast cancer or skin cancer (melanoma) has spread to the patient's lymph nodes.

The FDA said this is the first drug in over three decades approved for use in locating lymph nodes in cancer patients. Lymphoseek was approved on the basis of positive results from two studies involving 332 patients with breast cancer or melanoma. The drug located lymph nodes in a manner comparable to an older drug in these studies.

Navidea Biopharmaceuticals said in a statement that it was on the lookout for a partner to help distribute the drug outside the US.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Non-Hodgkins Lymphoma Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Burkitt’s Lymphoma Swollen Glands Swollen Lymph Nodes 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive